(2021) Crude venom of Pseudocerastes persicus snake: From the antibacterial to anticancer effects. Romanian Journal of Military Medicine. pp. 420-430. ISSN 1222-5126

(2021) Evaluation of in-vitro bactericidal activity and anticancer effects of venom fractions of Pseudocerastes persicus snake. Romanian Journal of Military Medicine. pp. 304-313. ISSN 1222-5126

(2020) Anti-cancer and anti-bacterial effects of crude venom of pseudocerastes persicus snake. Koomesh. pp. 518-528. ISSN 16087046 (ISSN)

(2018) EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E-coli O157: H7. Artificial Cells Nanomedicine and Biotechnology. S1067-S1075. ISSN 2169-1401

(2017) Designing Two Individual AcMNPV Polyhedrin-Plus Bac-to-Bac Expression System in order to Express GFP and CPV-VP2 in Insect Cells. Iranian Journal of Biotechnology. pp. 172-178. ISSN 1728-3043

(2017) Docking Studies, Synthesis, and In-vitro Evaluation of Novel Oximes Based on Nitrones as Reactivators of Inhibited Acetylcholinesterase. Iranian Journal of Pharmaceutical Research. pp. 880-892. ISSN 1735-0328

(2016) CONSTRUCTION OF A RECOMBINANT BACMID DNA ENCODING VIRAL PROTEIN-2 OF CANINE PARVOVIRUS USING SITE-SPECIFIC TRANSPOSITION MECHANISM. Iioab Journal. pp. 23-28. ISSN 0976-3104

(2016) Cloning, subcloning and recombination of VP2 gene of canine parvovirus into baculoviral shuttle vector enabling its expression in insect cells. Der Pharmacia Lettre. pp. 119-127. ISSN 09755071 (ISSN)

(2016) Design and in silico analysis of pentavalent chimeric antigen against three enteropathogenic bacteria: enterotoxigenic E. coli, enterohemorragic E. coli and Shigella. Bioscience Biotechnology Research Communications. pp. 229-243. ISSN 0974-6455

(2016) Expression and purification of recombinant TAT-BoNT/A((1-448)) under denaturing and native conditions. Bioengineered. pp. 478-483. ISSN 2165-5979

(2016) Generation of mini-Tn7 transposone by cloning of CPV-VP2 into eukaryotic expression cassette, in E. coli. International Journal of Pharmaceutical Research and Allied Sciences. pp. 343-349. ISSN 2277-3657

(2016) TAT-BoNT/A((1-448)), a novel fusion protein as a therapeutic agent: analysis of transcutaneous delivery and enzyme activity. Applied Microbiology and Biotechnology. pp. 2785-2795. ISSN 0175-7598

(2014) Nanoparticles in vaccine development. Journal of Applied Biotechnology Reports. pp. 125-134. ISSN 23221186 (ISSN)